Norovirus is surging across the U.S., with case numbers higher now than they've been at the same time in more than ... pathogens and bacterial vaccines at Moderna. So any vaccine would have ...
Cases of norovirus infections are surging, but coming up with a way to prevent them has proven to be a challenge.
3don MSN
While the headline numbers don't inspire much confidence, Moderna is a stock that deserves a closer look. The company still ...
The public health risk remains low, but bird flu variants have proven to be unpredictable, which is why the virus is a top ...
Robert F. Kennedy Jr. petitioned the F.D.A. to revoke authorization of the shots at a time when they were in high demand and ...
Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.
The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...
Moderna said on Friday. “Avian flu variants have proven to be particularly unpredictable and dangerous to humans in the past. Accelerating the development of new vaccines will allow us to stay ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback